Submission Details
| 510(k) Number | K233955 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 15, 2023 |
| Decision Date | June 14, 2024 |
| Days to Decision | 182 days |
| Submission Type | Traditional |
| Review Panel | Radiology (RA) |
| Summary | Summary PDF |
K233955 is an FDA 510(k) clearance for the Clarius OB AI, a System, Imaging, Pulsed Doppler, Ultrasonic (Class II — Special Controls, product code IYN), submitted by Clarius Mobile Health Corp. (Vancouver, CA). The FDA issued a Cleared decision on June 14, 2024, 182 days after receiving the submission on December 15, 2023. This device falls under the Radiology review panel. Regulated under 21 CFR 892.1550.
| 510(k) Number | K233955 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 15, 2023 |
| Decision Date | June 14, 2024 |
| Days to Decision | 182 days |
| Submission Type | Traditional |
| Review Panel | Radiology (RA) |
| Summary | Summary PDF |
| Product Code | IYN — System, Imaging, Pulsed Doppler, Ultrasonic |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 892.1550 |